Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines

INTRODUCTION: In Argentina, a pentavalent whole-cell pertussis vaccine (wP) is used in the National Immunization Program, however hexavalent acellular pertussis (aP) vaccines are available in the private market. OBJECTIVE: To describe parent or guardianś perceptions on reactogenicity, daily routine...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, Angela, Castellano, Vanesa Edelvais, Pacchiotti, Anabella, del Pino, Mariela, Bollón, Lucía Romero, Lieste, Micaela, Deluca, Mercedes, Vargas-Zambrano, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422674/
https://www.ncbi.nlm.nih.gov/pubmed/37577262
http://dx.doi.org/10.1016/j.jvacx.2023.100339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422674/
https://www.ncbi.nlm.nih.gov/pubmed/37577262
http://dx.doi.org/10.1016/j.jvacx.2023.100339

Ejemplares similares